Mbx Biosciences
(NASDAQ) MBX
Mbx Biosciences Financials at a Glance
Market Cap
$2.56B
Revenue (TTM)
$0.00
Net Income (TTM)
-$86.61M
EPS (TTM)
-$2.21
P/E Ratio
-24.38
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$53.93
Volume
0.028
Open
$52.64
Price
$53.93
Volume
0.028
Open
$52.64
Previous Close
$53.85
Daily Range
$52.12 - $55.00
52-Week Range
$9.63 - $55.00
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$53.93
Volume
0.028
Open
$52.64
Previous Close
$53.85
Daily Range
$52.12 - $55.00
52-Week Range
$9.63 - $55.00
Estimated Earnings Date
Aug 6, 2026
MBX News
MBX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mbx Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
63
CEO
Peter Kent Hawryluk, MBA
Website
www.mbxbio.comHeadquarters
Carmel, IN 46032, US
MBX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-24.50%
Return on Capital
-26.51%
Return on Assets
-19.13%
Earnings Yield
-4.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.56B
Shares Outstanding
47.60M
Volume
0.028
Avg. Volume
735.46K
Financials (TTM)
Gross Profit
-$224.00K
Operating Income
-$98.79M
EBITDA
-$86.37M
Operating Cash Flow
-$77.48M
Capital Expenditure
-$2.34M
Free Cash Flow
-$79.82M
Cash & ST Invst.
$439.98M
Total Debt
$555.00K
Mbx Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$64.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.56B
N/A
Market Cap/Employee
$59.61M
N/A
Employees
43
N/A
Net Income
-$23.52M
+1.5%
EBITDA
-$23.45M
+1.5%
Quarterly Fundamentals
Total Cash
$439.98M
+82.7%
Total Debt
$555.00K
+326.9%
Accounts Receivable
$3.16M
+127.9%
Inventory
$0.00
N/A
Long Term Debt
$377.00K
N/A
Short Term Debt
$178.00K
+36.9%
Return on Assets
-19.13%
N/A
Return on Invested Capital
-22.55%
N/A
Free Cash Flow
-$20.65M
+9.1%
Operating Cash Flow
-$20.21M
+10.9%